Tivantinib With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Locally Advanced Kidney Cancer That Cannot Be Removed by Surgery
Clinical trial NCT01688973 · COMPLETED
Trial details
- NCT number
- NCT01688973
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-20
- Primary completion
- 2017-04-30
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.